A nose-to-brain drug delivery approach leverages neural pathways to achieve high brain exposure with low systemic levels, offering a non-invasive alternative to transporter-based BBB strategies for ...

More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...

Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage on NeOnc Technologies Holdings, Inc. (NASDAQ: ...

“Being named a finalist by both CES and the Edison Awards is tremendously meaningful, reflecting the real-world impact of our work,” said Amy Gaston, Head of OhmBody. “It’s exciting to see women’s ...

Proliv™Rx therapy scales physician-directed brain neuromodulation beyond the clinic into the homeCORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for treating attention-deficit/hyperactivity disorder, does not effectively ...

Most days, our bodies are just there—mundane vessels we inhabit on autopilot. We wake up, get on with our routines, eat, sleep, repeat. But the moment you actually stop and think about what’s ...

Day to day, we exist in our bodies without thinking much about them. We wake up, eat, move around, and fall asleep again, all ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

MANGO, Fla. — As Hillsborough County Schools prepare to break for summer at the end of this week, Metropolitan Ministries has been scrambling to identify families on the verge of homelessness. It’s ...